Download PDF
CC BY 4.0 · Journal of Gastrointestinal and Abdominal Radiology 2024; 07(01): 027-054
DOI: 10.1055/s-0043-1772162
Review Article

Radiological Assessment of Sarcopenia and Its Clinical Impact in Patients with Hepatobiliary, Pancreatic, and Gastrointestinal Diseases: A Comprehensive Review

Shameema Farook
1   Department of Radiodiagnosis and Imaging, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India
,
Saumya Soni
1   Department of Radiodiagnosis and Imaging, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India
,
Arpit Shantagiri 
1   Department of Radiodiagnosis and Imaging, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India
,
Pankaj Gupta
1   Department of Radiodiagnosis and Imaging, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India
,
Anindita Sinha
1   Department of Radiodiagnosis and Imaging, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India
,
Mahesh Prakash
1   Department of Radiodiagnosis and Imaging, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India
› Author Affiliations Funding None declared.
› Further Information
Also available at
   Permissions and Reprints

Abstract

Sarcopenia is defined as a syndrome characterized by progressive and generalized loss of skeletal muscle mass and strength with a risk of adverse outcomes such as physical disability, poor quality of life, and death. The diagnosis of sarcopenia is based on documentation of two of the three criteria: low muscle mass, low muscle strength, and low physical performance. Imaging-based assessment of muscle mass is preferred in both clinical and research settings. Anthropometry for the evaluation of muscle mass is prone to errors and is not recommended in the clinical setting.

There is a lack of literature on the radiological assessment of sarcopenia and its association with prognosis in hepatobiliary, pancreatic, and gastrointestinal diseases. Thus, we aim to provide a review of studies that utilized radiological methods to assess sarcopenia and evaluate its impact on outcomes in patients with these diseases.

Keywords

sarcopenia - CT - MRI

Author Contribution

S.F.: data curation, writing—original draft preparation; S. S.: data curation, writing—original draft preparation; A. S.: data curation, writing—original draft preparation; P. G.: conceptualization, methodology, data curation, writing—original draft preparation, reviewing and editing; A. S.: writing—reviewing and rditing; M. P.: writing—reviewing and editing.




Publication History

Article published online:
04 August 2023

© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Cruz-Jentoft AJ, Baeyens JP, Bauer JM. et al; European Working Group on Sarcopenia in Older People. Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people. Age Ageing 2010; 39 (04) 412-423
    CrossrefPubMedGoogle Scholar
  • 2 Fielding RA, Vellas B, Evans WJ. et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc 2011; 12 (04) 249-256
    CrossrefPubMedGoogle Scholar
  • 3 Anker SD, Morley JE, von Haehling S. Welcome to the ICD-10 code for sarcopenia. J Cachexia Sarcopenia Muscle 2016; 7 (05) 512-514
    CrossrefPubMedGoogle Scholar
  • 4 Melton III LJ, Khosla S, Crowson CS, O'Connor MK, O'Fallon WM, Riggs BL. Epidemiology of sarcopenia. J Am Geriatr Soc 2000; 48 (06) 625-630
    CrossrefPubMedGoogle Scholar
  • 5 Cruz-Jentoft AJ, Sayer AA. Sarcopenia. Lancet 2019; 393 (10191): 2636-2646
    CrossrefPubMedGoogle Scholar
  • 6 Yu SC, Khow KS, Jadczak AD, Visvanathan R. Clinical screening tools for sarcopenia and its management. Curr Gerontol Geriatr Res 2016; 2016: 5978523
    PubMedGoogle Scholar
  • 7 Guerri S, Mercatelli D, Aparisi Gómez MP. et al. Quantitative imaging techniques for the assessment of osteoporosis and sarcopenia. Quant Imaging Med Surg 2018; 8 (01) 60-85
    CrossrefPubMedGoogle Scholar
  • 8 Peng P, Hyder O, Firoozmand A. et al. Impact of sarcopenia on outcomes following resection of pancreatic adenocarcinoma. J Gastrointest Surg 2012; 16 (08) 1478-1486
    CrossrefPubMedGoogle Scholar
  • 9 Tandon P, Ney M, Irwin I. et al. Severe muscle depletion in patients on the liver transplant wait list: its prevalence and independent prognostic value. Liver Transpl 2012; 18 (10) 1209-1216
    CrossrefPubMedGoogle Scholar
  • 10 Dodson RM, Firoozmand A, Hyder O. et al. Impact of sarcopenia on outcomes following intra-arterial therapy of hepatic malignancies. J Gastrointest Surg 2013; 17 (12) 2123-2132
    CrossrefPubMedGoogle Scholar
  • 11 Krell RW, Kaul DR, Martin AR. et al. Association between sarcopenia and the risk of serious infection among adults undergoing liver transplantation. Liver Transpl 2013; 19 (12) 1396-1402
    CrossrefPubMedGoogle Scholar
  • 12 Montano-Loza AJ, Meza-Junco J, Baracos VE. et al. Severe muscle depletion predicts postoperative length of stay but is not associated with survival after liver transplantation. Liver Transpl 2014; 20 (06) 640-648
    CrossrefPubMedGoogle Scholar
  • 13 Broughman JR, Williams GR, Deal AM. et al. Prevalence of sarcopenia in older patients with colorectal cancer. J Geriatr Oncol 2015; 6 (06) 442-445
    CrossrefPubMedGoogle Scholar
  • 14 Choi Y, Oh DY, Kim TY. et al. Skeletal muscle depletion predicts the prognosis of patients with advanced pancreatic cancer undergoing palliative chemotherapy, independent of body mass index. PLoS One 2015; 10 (10) e0139749
    CrossrefPubMedGoogle Scholar
  • 15 Fujiwara N, Nakagawa H, Kudo Y. et al. Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma. J Hepatol 2015; 63 (01) 131-140
    CrossrefPubMedGoogle Scholar
  • 16 Hamaguchi Y, Kaido T, Okumura S. et al. Preoperative intramuscular adipose tissue content is a novel prognostic predictor after hepatectomy for hepatocellular carcinoma. J Hepatobiliary Pancreat Sci 2015; 22 (06) 475-485
    CrossrefPubMedGoogle Scholar
  • 17 Hiraoka A, Aibiki T, Okudaira T. et al. Muscle atrophy as pre-sarcopenia in Japanese patients with chronic liver disease: computed tomography is useful for evaluation. J Gastroenterol 2015; 50 (12) 1206-1213
    CrossrefPubMedGoogle Scholar
  • 18 Iritani S, Imai K, Takai K. et al. Skeletal muscle depletion is an independent prognostic factor for hepatocellular carcinoma. J Gastroenterol 2015; 50 (03) 323-332
    CrossrefPubMedGoogle Scholar
  • 19 Jeon JY, Wang HJ, Ock SY. et al. Newly developed sarcopenia as a prognostic factor for survival in patients who underwent liver transplantation. PLoS One 2015; 10 (11) e0143966
    CrossrefPubMedGoogle Scholar
  • 20 Jones KI, Doleman B, Scott S, Lund JN, Williams JP. Simple psoas cross-sectional area measurement is a quick and easy method to assess sarcopenia and predicts major surgical complications. Colorectal Dis 2015; 17 (01) O20-O26
    CrossrefPubMedGoogle Scholar
  • 21 Levolger S, van Vledder MG, Muslem R. et al. Sarcopenia impairs survival in patients with potentially curable hepatocellular carcinoma. J Surg Oncol 2015; 112 (02) 208-213
    CrossrefPubMedGoogle Scholar
  • 22 Nault JC, Pigneur F, Nelson AC. et al. Visceral fat area predicts survival in patients with advanced hepatocellular carcinoma treated with tyrosine kinase inhibitors. Dig Liver Dis 2015; 47 (10) 869-876
    CrossrefPubMedGoogle Scholar
  • 23 Okumura S, Kaido T, Hamaguchi Y. et al. Impact of preoperative quality as well as quantity of skeletal muscle on survival after resection of pancreatic cancer. Surgery 2015; 157 (06) 1088-1098
    CrossrefPubMedGoogle Scholar
  • 24 Valero III V, Amini N, Spolverato G. et al. Sarcopenia adversely impacts postoperative complications following resection or transplantation in patients with primary liver tumors. J Gastrointest Surg 2015; 19 (02) 272-281
    CrossrefPubMedGoogle Scholar
  • 25 Voron T, Tselikas L, Pietrasz D. et al. Sarcopenia impacts on short- and long-term results of hepatectomy for hepatocellular carcinoma. Ann Surg 2015; 261 (06) 1173-1183
    CrossrefPubMedGoogle Scholar
  • 26 van Vugt JLA, Braam HJ, van Oudheusden TR. et al. Skeletal muscle depletion is associated with severe postoperative complications in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol 2015; 22 (11) 3625-3631
    CrossrefPubMedGoogle Scholar
  • 27 Zhang T, Cao L, Cao T. et al. Prevalence of sarcopenia and its impact on postoperative outcome in patients with Crohn's disease undergoing bowel resection. JPEN J Parenter Enteral Nutr 2017; 41 (04) 592-600
    CrossrefPubMedGoogle Scholar
  • 28 Kobayashi A, Kaido T, Hamaguchi Y. et al. Impact of postoperative changes in sarcopenic factors on outcomes after hepatectomy for hepatocellular carcinoma. J Hepatobiliary Pancreat Sci 2016; 23 (01) 57-64
    CrossrefPubMedGoogle Scholar
  • 29 Holt DQ, Strauss BJG, Lau KK, Moore GT. Body composition analysis using abdominal scans from routine clinical care in patients with Crohn's Disease. Scand J Gastroenterol 2016; 51 (07) 842-847
    CrossrefPubMedGoogle Scholar
  • 30 Fujikawa H, Araki T, Okita Y. et al. Impact of sarcopenia on surgical site infection after restorative proctocolectomy for ulcerative colitis. Surg Today 2017; 47 (01) 92-98
    CrossrefPubMedGoogle Scholar
  • 31 Hamaguchi Y, Kaido T, Okumura S. et al. Muscle steatosis is an independent predictor of postoperative complications in patients with hepatocellular carcinoma. World J Surg 2016; 40 (08) 1959-1968
    CrossrefPubMedGoogle Scholar
  • 32 Nishida Y, Kato Y, Kudo M. et al. Preoperative sarcopenia strongly influences the risk of postoperative pancreatic fistula formation after pancreaticoduodenectomy. J Gastrointest Surg 2016; 20 (09) 1586-1594
    CrossrefPubMedGoogle Scholar
  • 33 Reisinger KW, Derikx JPM, van Vugt JLA. et al. Sarcopenia is associated with an increased inflammatory response to surgery in colorectal cancer. Clin Nutr 2016; 35 (04) 924-927
    CrossrefPubMedGoogle Scholar
  • 34 Sandini M, Bernasconi DP, Fior D. et al. A high visceral adipose tissue-to-skeletal muscle ratio as a determinant of major complications after pancreatoduodenectomy for cancer. Nutrition 2016; 32 (11–12): 1231-1237
    CrossrefPubMedGoogle Scholar
  • 35 Zhang T, Ding C, Xie T. et al. Skeletal muscle depletion correlates with disease activity in ulcerative colitis and is reversed after colectomy. Clin Nutr 2017; 36 (06) 1586-1592
    CrossrefPubMedGoogle Scholar
  • 36 Yabusaki N, Fujii T, Yamada S. et al. Adverse impact of low skeletal muscle index on the prognosis of hepatocellular carcinoma after hepatic resection. Int J Surg 2016; 30: 136-142
    CrossrefPubMedGoogle Scholar
  • 37 Black D, Mackay C, Ramsay G. et al. Prognostic value of computed tomography: measured parameters of body composition in primary operable gastrointestinal cancers. Ann Surg Oncol 2017; 24 (08) 2241-2251
    CrossrefPubMedGoogle Scholar
  • 38 Bamba S, Sasaki M, Takaoka A. et al. Sarcopenia is a predictive factor for intestinal resection in admitted patients with Crohn's disease. PLoS One 2017; 12 (06) e0180036
    CrossrefPubMedGoogle Scholar
  • 39 Begini P, Gigante E, Antonelli G. et al. Sarcopenia predicts reduced survival in patients with hepatocellular carcinoma at first diagnosis. Ann Hepatol 2017; 16 (01) 107-114
    CrossrefPubMedGoogle Scholar
  • 40 Boer BC, de Graaff F, Brusse-Keizer M. et al. Skeletal muscle mass and quality as risk factors for postoperative outcome after open colon resection for cancer. Int J Colorectal Dis 2016; 31 (06) 1117-1124
    CrossrefPubMedGoogle Scholar
  • 41 Hamaguchi Y, Kaido T, Okumura S. et al. Impact of skeletal muscle mass index, intramuscular adipose tissue content, and visceral to subcutaneous adipose tissue area ratio on early mortality of living donor liver transplantation. Transplantation 2017; 101 (03) 565-574
    CrossrefPubMedGoogle Scholar
  • 42 Hanaoka M, Yasuno M, Ishiguro M. et al. Morphologic change of the psoas muscle as a surrogate marker of sarcopenia and predictor of complications after colorectal cancer surgery. Int J Colorectal Dis 2017; 32 (06) 847-856
    CrossrefPubMedGoogle Scholar
  • 43 Imai K, Takai K, Watanabe S. et al. Sarcopenia impairs prognosis of patients with hepatocellular carcinoma: the role of liver functional reserve and tumor-related factors in loss of skeletal muscle volume. Nutrients 2017; 9 (10) 1054
    CrossrefPubMedGoogle Scholar
  • 44 Cravo ML, Velho S, Torres J. et al. Lower skeletal muscle attenuation and high visceral fat index are associated with complicated disease in patients with Crohn's disease: an exploratory study. Clin Nutr ESPEN 2017; 21: 79-85
    CrossrefPubMedGoogle Scholar
  • 45 Nishikawa H, Nishijima N, Enomoto H. et al. Prognostic significance of sarcopenia in patients with hepatocellular carcinoma undergoing sorafenib therapy. Oncol Lett 2017; 14 (02) 1637-1647
    CrossrefPubMedGoogle Scholar
  • 46 Dedhia PH, White Y, Dillman JR. et al. Reduced paraspinous muscle area is associated with post-colectomy complications in children with ulcerative colitis. J Pediatr Surg 2018; 53 (03) 477-482
    CrossrefPubMedGoogle Scholar
  • 47 Pedersen M, Cromwell J, Nau P. Sarcopenia is a predictor of surgical morbidity in inflammatory bowel disease. Inflamm Bowel Dis 2017; 23 (10) 1867-1872
    CrossrefPubMedGoogle Scholar
  • 48 van Roekel EH, Bours MJL, Te Molder MEM. et al. Associations of adipose and muscle tissue parameters at colorectal cancer diagnosis with long-term health-related quality of life. Qual Life Res 2017; 26 (07) 1745-1759
    CrossrefPubMedGoogle Scholar
  • 49 Shintakuya R, Uemura K, Murakami Y. et al. Sarcopenia is closely associated with pancreatic exocrine insufficiency in patients with pancreatic disease. Pancreatology 2017; 17 (01) 70-75
    CrossrefPubMedGoogle Scholar
  • 50 Takagi K, Yoshida R, Yagi T. et al. Radiographic sarcopenia predicts postoperative infectious complications in patients undergoing pancreaticoduodenectomy. BMC Surg 2017; 17 (01) 64
    CrossrefPubMedGoogle Scholar
  • 51 van Vugt JLA, Buettner S, Levolger S. et al. Low skeletal muscle mass is associated with increased hospital expenditure in patients undergoing cancer surgery of the alimentary tract. PLoS One 2017; 12 (10) e0186547
    CrossrefPubMedGoogle Scholar
  • 52 Wada Y, Kamishima T, Shimamura T. et al. Pre-operative volume rather than area of skeletal muscle is a better predictor for post-operative risks for respiratory complications in living-donor liver transplantation. Br J Radiol 2017; 90 (1072) 20160938
    CrossrefPubMedGoogle Scholar
  • 53 Yamashima M, Miyaaki H, Honda T. et al. Significance of psoas muscle thickness as an indicator of muscle atrophy in patients with hepatocellular carcinoma treated with sorafenib. Mol Clin Oncol 2017; 7 (03) 449-453
    CrossrefPubMedGoogle Scholar
  • 54 Yoon SB, Choi MH, Lee IS. et al. Impact of body fat and muscle distribution on severity of acute pancreatitis. Pancreatology 2017; 17 (02) 188-193
    CrossrefPubMedGoogle Scholar
  • 55 Ozola-Zālīte I, Frøkjær JB, Mark EB. et al. A clinical feasible method for computed tomography-based assessment of sarcopenia in patients with chronic pancreatitis. Pancreas 2019; 48 (10) 1354-1359
    CrossrefPubMedGoogle Scholar
  • 56 Antonelli G, Gigante E, Iavarone M. et al. Sarcopenia is associated with reduced survival in patients with advanced hepatocellular carcinoma undergoing sorafenib treatment. United European Gastroenterol J 2018; 6 (07) 1039-1048
    CrossrefPubMedGoogle Scholar
  • 57 Chae MS, Moon KU, Jung JY. et al. Perioperative loss of psoas muscle is associated with patient survival in living donor liver transplantation. Liver Transpl 2018; 24 (05) 623-633
    CrossrefPubMedGoogle Scholar
  • 58 van der Kroft G, Bours DMJL, Janssen-Heijnen DM, van Berlo DCLH, Konsten DJLM. Value of sarcopenia assessed by computed tomography for the prediction of postoperative morbidity following oncological colorectal resection: A comparison with the malnutrition screening tool. Clin Nutr ESPEN 2018; 24: 114-119
    CrossrefPubMedGoogle Scholar
  • 59 Deng CY, Lin YC, Wu JS. et al. Progressive sarcopenia in patients with colorectal cancer predicts survival. AJR Am J Roentgenol 2018; 210 (03) 526-532
    CrossrefPubMedGoogle Scholar
  • 60 Huguet A, Latournerie M, Debry PH. et al. The psoas muscle transversal diameter predicts mortality in patients with cirrhosis on a waiting list for liver transplantation: a retrospective cohort study. Nutrition 2018; 51–52: 73-79
    CrossrefPubMedGoogle Scholar
  • 61 Kobayashi T, Kawai H, Nakano O. et al. Rapidly declining skeletal muscle mass predicts poor prognosis of hepatocellular carcinoma treated with transcatheter intra-arterial therapies. BMC Cancer 2018; 18 (01) 756
    CrossrefPubMedGoogle Scholar
  • 62 Levolger S, van Vledder MG, Alberda WJ. et al. Muscle wasting and survival following pre-operative chemoradiotherapy for locally advanced rectal carcinoma. Clin Nutr 2018; 37 (05) 1728-1735
    CrossrefPubMedGoogle Scholar
  • 63 Praktiknjo M, Book M, Luetkens J. et al. Fat-free muscle mass in magnetic resonance imaging predicts acute-on-chronic liver failure and survival in decompensated cirrhosis. Hepatology 2018; 67 (03) 1014-1026
    CrossrefPubMedGoogle Scholar
  • 64 Shirai H, Kaido T, Hamaguchi Y. et al. Preoperative low muscle mass and low muscle quality negatively impact on pulmonary function in patients undergoing hepatectomy for hepatocellular carcinoma. Liver Cancer 2018; 7 (01) 76-89
    CrossrefPubMedGoogle Scholar
  • 65 Sugimoto M, Farnell MB, Nagorney DM. et al. Decreased skeletal muscle volume is a predictive factor for poorer survival in patients undergoing surgical resection for pancreatic ductal adenocarcinoma. J Gastrointest Surg 2018; 22 (05) 831-839
    CrossrefPubMedGoogle Scholar
  • 66 Tachi Y, Kozuka A, Hirai T. et al. Impact of myosteatosis on skeletal muscle volume loss in patients with chronic liver disease. J Gastroenterol Hepatol 2018; 33 (09) 1659-1666
    CrossrefPubMedGoogle Scholar
  • 67 Tachi Y, Kozuka A, Hirai T. et al. Skeletal muscle fat deposition is associated with hepatocellular carcinoma development in patients with chronic liver disease. Nutrition 2018; 54: 83-88
    CrossrefPubMedGoogle Scholar
  • 68 Takada H, Kurosaki M, Nakanishi H. et al. Impact of pre-sarcopenia in sorafenib treatment for advanced hepatocellular carcinoma. PLoS One 2018; 13 (06) e0198812
    CrossrefPubMedGoogle Scholar
  • 69 Thiberge C, Charpentier C, Gillibert A. et al. Lower subcutaneous or visceral adiposity assessed by abdominal computed tomography could predict adverse outcome in patients with Crohn's disease. J Crohn's Colitis 2018; 12 (12) 1429-1437
    CrossrefPubMedGoogle Scholar
  • 70 van Vugt JLA, Buettner S, Alferink LJM. et al. Low skeletal muscle mass is associated with increased hospital costs in patients with cirrhosis listed for liver transplantation-a retrospective study. Transpl Int 2018; 31 (02) 165-174
    CrossrefPubMedGoogle Scholar
  • 71 Moctezuma-Velázquez C, Low G, Mourtzakis M. et al. Association between low testosterone levels and sarcopenia in cirrhosis: a cross-sectional study. Ann Hepatol 2018; 17 (04) 615-623
    CrossrefPubMedGoogle Scholar
  • 72 van Vugt JLA, Coebergh van den Braak RRJ, Lalmahomed ZS. et al. Impact of low skeletal muscle mass and density on short and long-term outcome after resection of stage I-III colorectal cancer. Eur J Surg Oncol 2018; 44 (09) 1354-1360
    CrossrefPubMedGoogle Scholar
  • 73 Xiao J, Caan BJ, Weltzien E. et al. Associations of pre-existing co-morbidities with skeletal muscle mass and radiodensity in patients with non-metastatic colorectal cancer. J Cachexia Sarcopenia Muscle 2018; 9 (04) 654-663
    CrossrefPubMedGoogle Scholar
  • 74 Acosta LF, Galuppo R, García CR. et al. Association between sarcopenia and AFP level in patients undergoing liver transplantation for hepatocellular carcinoma. J Surg Res 2019; 238: 10-15
    CrossrefPubMedGoogle Scholar
  • 75 Bieliuniene E, Brøndum Frøkjær J, Pockevicius A. et al. CT- and MRI-based assessment of body composition and pancreatic fibrosis reveals high incidence of clinically significant metabolic changes that affect the quality of life and treatment outcomes of patients with chronic pancreatitis and pancreatic cancer. Medicina (Kaunas) 2019; 55 (10) 649
    CrossrefPubMedGoogle Scholar
  • 76 Choi MH, Oh SN, Lee IK, Oh ST, Won DD. Sarcopenia is negatively associated with long-term outcomes in locally advanced rectal cancer. J Cachexia Sarcopenia Muscle 2018; 9 (01) 53-59
    CrossrefPubMedGoogle Scholar
  • 77 Dohzono S, Sasaoka R, Takamatsu K, Hoshino M, Nakamura H. Prognostic value of paravertebral muscle density in patients with spinal metastases from gastrointestinal cancer. Support Care Cancer 2019; 27 (04) 1207-1213
    CrossrefPubMedGoogle Scholar
  • 78 Esser H, Resch T, Pamminger M. et al. Preoperative assessment of muscle mass using computerized tomography scans to predict outcomes following orthotopic liver transplantation. Transplantation 2019; 103 (12) 2506-2514
    CrossrefPubMedGoogle Scholar
  • 79 Galata C, Hodapp J, Weiß C. et al. Skeletal muscle mass index predicts postoperative complications in intestinal surgery for Crohn's disease. JPEN J Parenter Enteral Nutr 2020; 44 (04) 714-721
    CrossrefPubMedGoogle Scholar
  • 80 Hamaguchi Y, Kaido T, Okumura S. et al. Preoperative visceral adiposity and muscularity predict poor outcomes after hepatectomy for hepatocellular carcinoma. Liver Cancer 2019; 8 (02) 92-109
    CrossrefPubMedGoogle Scholar
  • 81 Herrod PJJ, Boyd-Carson H, Doleman B. et al. Quick and simple; psoas density measurement is an independent predictor of anastomotic leak and other complications after colorectal resection. Tech Coloproctol 2019; 23 (02) 129-134
    CrossrefPubMedGoogle Scholar
  • 82 Jang M, Park HW, Huh J. et al. Predictive value of sarcopenia and visceral obesity for postoperative pancreatic fistula after pancreaticoduodenectomy analyzed on clinically acquired CT and MRI. Eur Radiol 2019; 29 (05) 2417-2425
    CrossrefPubMedGoogle Scholar
  • 83 Jochum SB, Kistner M, Wood EH. et al. Is sarcopenia a better predictor of complications than body mass index? Sarcopenia and surgical outcomes in patients with rectal cancer. Colorectal Dis 2019; 21 (12) 1372-1378
    CrossrefPubMedGoogle Scholar
  • 84 Kamo N, Kaido T, Hamaguchi Y. et al. Impact of sarcopenic obesity on outcomes in patients undergoing living donor liver transplantation. Clin Nutr 2019; 38 (05) 2202-2209
    CrossrefPubMedGoogle Scholar
  • 85 Kitano Y, Yamashita YI, Saito Y. et al. Sarcopenia affects systemic and local immune system and impacts postoperative outcome in patients with extrahepatic cholangiocarcinoma. World J Surg 2019; 43 (09) 2271-2280
    CrossrefPubMedGoogle Scholar
  • 86 Kobayashi A, Kaido T, Hamaguchi Y. et al. Impact of sarcopenic obesity on outcomes in patients undergoing hepatectomy for hepatocellular carcinoma. Ann Surg 2019; 269 (05) 924-931
    CrossrefPubMedGoogle Scholar
  • 87 Kuo SZ, Ahmad M, Dunn MA. et al. Sarcopenia predicts post-transplant mortality in acutely ill men undergoing urgent evaluation and liver transplantation. Transplantation 2019; 103 (11) 2312-2317
    CrossrefPubMedGoogle Scholar
  • 88 Lindqvist C, Brismar TB, Majeed A, Wahlin S. Assessment of muscle mass depletion in chronic liver disease: dual-energy X-ray absorptiometry compared with computed tomography. Nutrition 2019; 61: 93-98
    CrossrefPubMedGoogle Scholar
  • 89 Mardian Y, Yano Y, Ratnasari N. et al. “Sarcopenia and intramuscular fat deposition are associated with poor survival in Indonesian patients with hepatocellular carcinoma: a retrospective study”. BMC Gastroenterol 2019; 19 (01) 229
    CrossrefPubMedGoogle Scholar
  • 90 Praktiknjo M, Clees C, Pigliacelli A. et al. Sarcopenia is associated with development of acute-on-chronic liver failure in decompensated liver cirrhosis receiving transjugular intrahepatic portosystemic shunt. Clin Transl Gastroenterol 2019; 10 (04) e00025
    CrossrefPubMedGoogle Scholar
  • 91 Agalar C, Sokmen S, Arslan C. et al. The impact of sarcopenia on morbidity and long-term survival among patients with peritoneal metastases of colorectal origin treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a 10-year longitudinal analysis of a single-center experience. Tech Coloproctol 2020; 24 (04) 301-308
    CrossrefPubMedGoogle Scholar
  • 92 Badran H, Elsabaawy MM, Ragab A, Aly RA, Alsebaey A, Sabry A. Baseline sarcopenia is associated with lack of response to therapy, liver decompensation and high mortality in hepatocellular carcinoma patients. Asian Pac J Cancer Prev 2020; 21 (11) 3285-3290
    CrossrefPubMedGoogle Scholar
  • 93 Beer L, Bastati N, Ba-Ssalamah A. et al. MRI-defined sarcopenia predicts mortality in patients with chronic liver disease. Liver Int 2020; 40 (11) 2797-2807
    CrossrefPubMedGoogle Scholar
  • 94 Cabo SN, León Díaz FJ, Segura JS. et al. Influence of preoperative muscle mass assessed by computed tomography on prognosis after liver transplantation. Transplant Proc 2020; 52 (02) 537-539
    CrossrefPubMedGoogle Scholar
  • 95 Celentano V, Kamil-Mustafa L, Beable R. et al. Preoperative assessment of skeletal muscle mass during magnetic resonance enterography in patients with Crohn's disease. Updates Surg 2021; 73 (04) 1419-1427
    CrossrefPubMedGoogle Scholar
  • 96 Dhaliwal A, Larson D, Hiat M. et al. Impact of sarcopenia on mortality in patients undergoing liver re-transplantation. World J Hepatol 2020; 12 (10) 807-815
    CrossrefPubMedGoogle Scholar
  • 97 Pinto Dos Santos D, Kloeckner R, Koch S. et al. Sarcopenia as prognostic factor for survival after orthotopic liver transplantation. Eur J Gastroenterol Hepatol 2020; 32 (05) 626-634
    CrossrefPubMedGoogle Scholar
  • 98 Han JS, Ryu H, Park IJ. et al. Association of body composition with long-term survival in non-metastatic rectal cancer patients. Cancer Res Treat 2020; 52 (02) 563-572
    CrossrefPubMedGoogle Scholar
  • 99 Grillot J, D'Engremont C, Parmentier AL. et al. Sarcopenia and visceral obesity assessed by computed tomography are associated with adverse outcomes in patients with Crohn's disease. Clin Nutr 2020; 39 (10) 3024-3030
    CrossrefPubMedGoogle Scholar
  • 100 Romagna ES, Appel-da-Silva MC, Suwa E, Maeda FK, Mattos AA, Tovo CV. Muscle depletion in cirrhotic patients assessed using computed tomography: a cross-sectional study. Sao Paulo Med J 2020; 138 (02) 152-157
    CrossrefPubMedGoogle Scholar
  • 101 Salman MA, Omar HSE, Mikhail HMS. et al. Sarcopenia increases 1-year mortality after surgical resection of hepatocellular carcinoma. ANZ J Surg 2020; 90 (05) 781-785
    CrossrefPubMedGoogle Scholar
  • 102 Schaffler-Schaden D, Mittermair C, Birsak T. et al. Skeletal muscle index is an independent predictor of early recurrence in non-obese colon cancer patients. Langenbecks Arch Surg 2020; 405 (04) 469-477
    CrossrefPubMedGoogle Scholar
  • 103 Shakhbazov R, Pattarabanjird O, Brayman KL, Alekberzade AV, Krylov NN. Morphometry of adipose tissue for prediction of the outcomes of total pancreatectomy with pancreatic islets autotransplantation in patients with chronic pancreatitis [in Russian]. Khirurgiia (Mosk) 2020; (05) 12-19
    PubMedGoogle Scholar
  • 104 Shirdel M, Andersson F, Myte R. et al. Body composition measured by computed tomography is associated with colorectal cancer survival, also in early-stage disease. Acta Oncol 2020; 59 (07) 799-808
    CrossrefPubMedGoogle Scholar
  • 105 Takada H, Amemiya F, Yasumura T. et al. Relationship between presarcopenia and event occurrence in patients with primary hepatocellular carcinoma. Sci Rep 2020; 10 (01) 10186
    CrossrefPubMedGoogle Scholar
  • 106 Tankel J, Yellinek S, Vainberg E. et al. Sarcopenia defined by muscle quality rather than quantity predicts complications following laparoscopic right hemicolectomy. Int J Colorectal Dis 2020; 35 (01) 85-94
    CrossrefPubMedGoogle Scholar
  • 107 Trikudanathan G, Feussom G, Teigen L. et al. Pre-operative sarcopenia predicts low islet cell yield following total pancreatectomy with islet autotransplantation for chronic pancreatitis. J Gastrointest Surg 2020; 24 (10) 2423-2430
    CrossrefPubMedGoogle Scholar
  • 108 Xie H, Gong Y, Kuang J. et al. Computed tomography-determined sarcopenia is a useful imaging biomarker for predicting postoperative outcomes in elderly colorectal cancer patients. Cancer Res Treat 2020; 52 (03) 957-972
    CrossrefPubMedGoogle Scholar
  • 109 Yeh WS, Chiang PL, Kee KM. et al. Pre-sarcopenia is the prognostic factor of overall survival in early-stage hepatoma patients undergoing radiofrequency ablation. Medicine (Baltimore) 2020; 99 (23) e20455
    CrossrefPubMedGoogle Scholar
  • 110 Zager Y, Khalilieh S, Ganaiem O. et al. Low psoas muscle area is associated with postoperative complications in Crohn's disease. Int J Colorectal Dis 2021; 36 (03) 543-550
    CrossrefPubMedGoogle Scholar
  • 111 Akce M, Liu Y, Zakka K. et al. Impact of sarcopenia, BMI, and inflammatory biomarkers on survival in advanced hepatocellular carcinoma treated with anti-PD-1 antibody. Am J Clin Oncol 2021; 44 (02) 74-81
    CrossrefPubMedGoogle Scholar
  • 112 Akturk Y, Ozbal Gunes S, Hekimoglu B. The effects of the fat distribution of body, skeletal muscle mass and muscle quality on acute pancreatitis severity: a retrospective cross-sectional study. J Comput Assist Tomogr 2021; 45 (04) 500-506
    CrossrefPubMedGoogle Scholar
  • 113 Alsebaey A, Sabry A, Rashed HS. et al. MELD-sarcopenia is better than ALBI and MELD score in patients with hepatocellular carcinoma awaiting liver transplantation. Asian Pac J Cancer Prev 2021; 22 (07) 2005-2009
    CrossrefPubMedGoogle Scholar
  • 114 Argillander TE, Spek D, van der Zaag-Loonen HJ, van Raamt AF, van Duijvendijk P, van Munster BC. Association between postoperative muscle wasting and survival in older patients undergoing surgery for non-metastatic colorectal cancer. J Geriatr Oncol 2021; 12 (07) 1052-1058
    CrossrefPubMedGoogle Scholar
  • 115 Bamba S, Inatomi O, Takahashi K. et al. Assessment of body composition from CT images at the level of the third lumbar vertebra in inflammatory bowel disease. Inflamm Bowel Dis 2021; 27 (09) 1435-1442
    CrossrefPubMedGoogle Scholar
  • 116 Box EW, Deng L, Morgan DE. et al. Preoperative anthropomorphic radiographic measurements can predict postoperative pancreatic fistula formation following pancreatoduodenectomy. Am J Surg 2021; 222 (01) 133-138
    CrossrefPubMedGoogle Scholar
  • 117 Cárcamo L, Peñailillo E, Bellolio F. et al. Computed tomography-measured body composition parameters do not influence survival in non-metastatic colorectal cancer. ANZ J Surg 2021; 91 (05) E298-E306
    CrossrefPubMedGoogle Scholar
  • 118 Boparai G, Kedia S, Kandasamy D. et al. Combination of sarcopenia and high visceral fat predict poor outcomes in patients with Crohn's disease. Eur J Clin Nutr 2021; 75 (10) 1491-1498
    CrossrefPubMedGoogle Scholar
  • 119 Guichet PL, Taslakian B, Zhan C. et al. MRI-derived sarcopenia associated with increased mortality following yttrium-90 radioembolization of hepatocellular carcinoma. Cardiovasc Intervent Radiol 2021; 44 (10) 1561-1569
    CrossrefPubMedGoogle Scholar
  • 120 Irwin NEA, Fabian J, Hari KR, Lorentz L, Mahomed A, Botha JF. Myosteatosis, the more significant predictor of outcome: an analysis of the impact of myosteatosis, sarcopenia, and sarcopenic obesity on liver transplant outcomes in Johannesburg, South Africa. Exp Clin Transplant 2021; 19 (09) 948-955
    CrossrefPubMedGoogle Scholar
  • 121 Jang HY, Choi GH, Hwang SH. et al. Sarcopenia and visceral adiposity predict poor overall survival in hepatocellular carcinoma patients after curative hepatic resection. Transl Cancer Res 2021; 10 (02) 854-866
    CrossrefPubMedGoogle Scholar
  • 122 Lee C, Park IJ, Kim KW. et al. Influence of postoperative changes in sarcopenia on long-term survival in non-metastatic colorectal cancer patients. Cancers (Basel) 2021; 13 (10) 2410
    CrossrefPubMedGoogle Scholar
  • 123 Lim J, Kim KW, Ko Y. et al. The role of muscle depletion and visceral adiposity in HCC patients aged 65 and over undergoing TACE. BMC Cancer 2021; 21 (01) 1164
    CrossrefPubMedGoogle Scholar
  • 124 Maddalena C, Ponsiglione A, Camera L. et al. Prognostic role of sarcopenia in metastatic colorectal cancer patients during first-line chemotherapy: a retrospective study. World J Clin Oncol 2021; 12 (05) 355-366
    CrossrefPubMedGoogle Scholar
  • 125 Mihai F, Trifan A, Stanciu C. et al. L3 skeletal muscle index dynamics in patients with HCV-related compensated cirrhosis following sustained virological response after direct acting antiviral treatment. Medicina (Kaunas) 2021; 57 (11) 1226
    CrossrefPubMedGoogle Scholar
  • 126 Salinas-Miranda E, Deniffel D, Dong X. et al. Prognostic value of early changes in CT-measured body composition in patients receiving chemotherapy for unresectable pancreatic cancer. Eur Radiol 2021; 31 (11) 8662-8670
    CrossrefPubMedGoogle Scholar
  • 127 Murachi Y, Sakai D, Koseki J. et al. Impact of sarcopenia in patients with advanced or recurrent colorectal cancer treated with regorafenib. Int J Clin Oncol 2021; 26 (02) 409-416
    CrossrefPubMedGoogle Scholar
  • 128 Paternostro R, Bardach C, Hofer BS. et al. Prognostic impact of sarcopenia in cirrhotic patients stratified by different severity of portal hypertension. Liver Int 2021; 41 (04) 799-809
    CrossrefPubMedGoogle Scholar
  • 129 Qayyum A, Bhosale P, Aslam R. et al. Effect of sarcopenia on systemic targeted therapy response in patients with advanced hepatocellular carcinoma. Abdom Radiol (NY) 2021; 46 (03) 1008-1015
    CrossrefPubMedGoogle Scholar
  • 130 Jördens MS, Heinrichs L, Loosen SH. et al. Sarcopenia predicts cancer mortality in male but not in female patients undergoing surgery for cholangiocellular carcinoma. Cancers (Basel) 2021; 13 (21) 5359
    CrossrefPubMedGoogle Scholar
  • 131 Seror M, Sartoris R, Hobeika C. et al. Computed tomography-derived liver surface nodularity and sarcopenia as prognostic factors in patients with resectable metabolic syndrome-related hepatocellular carcinoma. Ann Surg Oncol 2021; 28 (01) 405-416
    CrossrefPubMedGoogle Scholar
  • 132 Williet N, Fovet M, Maoui K. et al. A low total psoas muscle area index is a strong prognostic factor in metastatic pancreatic cancer. Pancreas 2021; 50 (04) 579-586
    CrossrefPubMedGoogle Scholar
  • 133 Wu CH, Liang PC, Hsu CH, Chang FT, Shao YY, Ting-Fang Shih T. Total skeletal, psoas and rectus abdominis muscle mass as prognostic factors for patients with advanced hepatocellular carcinoma. J Formos Med Assoc 2021; 120 (1, Pt 2): 559-566
    CrossrefPubMedGoogle Scholar
  • 134 Wu MY, Lim WX, Cheng YF. et al. Sarcopenia adversely impacts postoperative complications in living-donor liver transplantation recipients. Sci Rep 2021; 11 (01) 19247
    CrossrefPubMedGoogle Scholar
  • 135 Yasueda A, Sekido Y, Takeda T. et al. Sarcopenia hinders the decline in disease activity after surgery for people with Crohn's disease: Preliminary results. Nutrition 2022; 94: 111526
    CrossrefPubMedGoogle Scholar
  • 136 Yıldırım İ, Kaya T, İşsever K. et al. Psoas muscle mass, nutritional status, inflammation, and their relationship with prognosis in patients with pancreatic adenocarcinoma. Nutr Hosp 2021; 38 (05) 1009-1015
    PubMedGoogle Scholar
  • 137 Zheng X, Cao F, Qian L, Dong J. Body composition changes in hepatocellular carcinoma: prediction of survival to transcatheter arterial chemoembolization in combination with clinical prognostic factors. Cancer Contr 2021; 28: 10 732748211038445
    Google Scholar
  • 138 Wackenthaler A, Molière S, Artzner T. et al. Pre-operative CT scan helps predict outcome after liver transplantation for acute-on-chronic grade 3 liver failure. Eur Radiol 2022; 32 (01) 12-21
    CrossrefPubMedGoogle Scholar
  • 139 Chong J, Guorgui J, Coy H. et al. Perioperative skeletal muscle fluctuations in high-acuity liver transplantation. J Surg Res 2022; 270: 386-393
    CrossrefPubMedGoogle Scholar
  • 140 da Silva Dias D, Machado M, Trabulo C, Gosálbez B, Ravasco P. Impact of body composition on prognosis and dose-limiting toxicities on metastatic colorectal cancer. Front Nutr 2022; 8: 671547
    CrossrefPubMedGoogle Scholar
  • 141 Özkul B, Özkul Ö, Bilir C. Predicting the overall survival in patients with advanced pancreatic cancer by calculating L3 skeletal muscle index derived from CT. Curr Med Imaging 2022; 18 (10) 1079-1085
    CrossrefPubMedGoogle Scholar
  • 142 Rom H, Tamir S, Van Vugt JLA. et al. Sarcopenia as a predictor of survival in patients with pancreatic adenocarcinoma after pancreatectomy. Ann Surg Oncol 2022; 29 (03) 1553-1563
    CrossrefPubMedGoogle Scholar
  • 143 Sato R, Oikawa M, Kakita T. et al. Impact of sarcopenia on postoperative complications in obstructive colorectal cancer patients who received stenting as a bridge to curative surgery. J Anus Rectum Colon 2022; 6 (01) 40-51
    CrossrefPubMedGoogle Scholar
  • 144 Kim IH, Choi MH, Lee IS, Hong TH, Lee MA. Clinical significance of skeletal muscle density and sarcopenia in patients with pancreatic cancer undergoing first-line chemotherapy: a retrospective observational study. BMC Cancer 2021; 21 (01) 77
    CrossrefPubMedGoogle Scholar